| Target Price | $36.72 |
| Price | $8.23 |
| Potential |
346.17%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Homology Medicines, Inc. 2027 .
The average Homology Medicines, Inc. target price is $36.72.
This is
346.17%
register free of charge
$61.95
652.73%
register free of charge
$34.34
317.25%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Homology Medicines, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Homology Medicines, Inc. stock has an average upside potential 2027 of
346.17%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Sep 28 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | May 22 2026 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | May 18 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Sep 28 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
May 22 2026 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
May 18 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


